Celularity Inc. (CELU) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Celularity Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.94
+18.97% today
Market cap
$26M
Overall quality
28/100
Kronos AI 30-day
—
Celularity Inc. (CELU) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $26M. It trades at $0.94, up 18.97% today. Its overall quality score is 28 out of 100, ranked against the whole US market.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 22 |
| Solvency | 24 |
| Growth | 38 |
| Overall | 28 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.